Cyclosporine metabolism in patients after kidney, bone marrow, heart-lung, and liver transplantation in the early and late posttransplant periods

American Journal of Clinical Pathology

Volumn 114, Issue 4, 2000, Pages 536-543

  Hamwi, Ahmad ^a   Salomon, Alexandra ^a   Steinbrugger, Richard ^a   Fritzer Szekeres, Monika ^a   Jäger, Walter ^a   Szekeres, Thomas ^a,b  

^a UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

CEDIA; Cloned enzyme donor immunoassay; Cyclosporine; EMIT; Enzyme multiplied immunoassay; Fluorescence polarization immunoassay; FPIA; High performance liquid chromatography; HPLC; Metabolism; Transplant recipients

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A;

ADULT; ARTICLE; BONE MARROW TRANSPLANTATION; CROSS REACTION; DOSE CALCULATION; DRUG BLOOD LEVEL; DRUG METABOLISM; ENZYME MULTIPLIED IMMUNOASSAY TECHNIQUE; FEMALE; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEART LUNG TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; ORGAN TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL;

BONE MARROW TRANSPLANTATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYCLOSPORINE; FEMALE; HEART-LUNG TRANSPLANTATION; HUMANS; IMMUNOASSAY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 0034425004     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/8PGN-0C9E-3NB9-CJK5     Document Type: Article

References (15)

1. Kahan BD. Cyclosporin A. N Engl J Med. 1989;321:1725-1738.
2. Lindholm A. Therapeutic monitoring of cyclosporin A: an update. Eur J Clin Pharmacol. 1991;41:273-283.
3. Maurer G, Lemaire M. Biotransformation and distribution in blood of cyclosporine and its metabolites. Transplant Proc. 1986;18(6 suppl 15):25-34.
4. Maurer G, Loosli HR, Schreier E, et al. Disposition of cyclosporine in several animal species and man, I: structural elucidation of its metabolites. Drug Metab Dispos. 1984; 12:120-126.
5. Ryffel B, Foxwell BMJ, Mihatsch MJ, et al. Biologic significance of cyclosporine metabolites. Transplant Proc. 1988;20:575-584.
6. Wang CP, Burckart GJ, Ptachcinski RJ, et al. Cyclosporine metabolite concentrations in the blood of liver, heart, kidney, and bone marrow transplant patients. Transplant Proc. 1988;20:591-596.
7. Schütz E, Svinarov D, Shipkova M, et al. Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC. Clin Chem. 1998;44:2158-2164.
8. Steimer W. Performance and specificity of monoclonal immunoassays for cyclosporine monitoring: how specific is specific? Clin Chem. 1999;45:371-381.
9. Hamwi A, Veitl M, Männer G, et al. Evaluation of four automated methods for determination of whole blood cyclosporine concentrations. Am J Clin Pathol. 1999;112:358-365.
10. De Groen PC. Cyclosporin A and the liver, How one effects the other. Transpl Proc. 1991;22:1197-1202.
11. Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise Consensus Conference on cyclosporine monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit. 1995;17:642-654.
12. Christians U, Zimmer KO, Wonigert K, et al. Liquid-chromatographic measurement of cyclosporin A and its metabolites in blood, bile, and urine. Clin Chem. 1988;34:34-39.
13. Yatscoff RW, Copeland KR, Faraci CJ. Abbott TDx monoclonal antibody assay evaluated for measuring cyclosporine in whole blood. Clin Chem. 1990;36:1969-1973.
14. Freeman DJ. Pharmacology and pharmacokinetics of cyclosporine. Clin Biochem. 1991;24:9-14.
15. Witzke O, Heemann U, Thesing A, et al. A comparison of EMIT and FPIA methods for the detection of cyclosporine A blood levels: does impaired liver function make a difference ? Eur J Clin Pharmacol. 1997;52:423-416.